In this episode, Shoshana Lipson shares anecdotal reports about using CGRP medications for migraine compiled by surveying the 6,000+ member Facebook group CGRP and Migraine
Community, which she founded. She details the findings in four areas: Efficacy & expectations, adverse side effects, accessibility and information flow. Most importantly, her studies include a broader range of patients than those permitted in clinical trials, allowing for a potentially more realistic look into the implications and outcomes of using CGRP antagonists.

This podcast is sponsored in part by Amgen/Novartis and
Alder BioPharmaceuticals.

*The contents of this podcast/video are intended for general informational purposes only and do not constitute medical or legal advice; the content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. The speaker does not recommend or endorse any specific course of treatment, products, procedures, opinions, or other information that may be mentioned. Reliance on any information provided by this content is solely at your own risk.